Cubbie Conference December 10, 2026 in San Francisco Get tickets →

AI platform for drug discovery using generative AI to design novel molecular structures for clinical development.

Pricing

Custom quote

Founded

2014

Team size

201-500 employees

Headquarters

New York, NY

Product Preview

Insilico Medicine preview

Preview from insilico.com

At a glance

Pricing model

Custom quote

Security

ISO 27001

About Insilico Medicine

Insilico Medicine is a biotech that applies generative AI and deep learning to end-to-end drug discovery. Its Pharma.AI platform identifies disease targets, designs novel small-molecule and biologic candidates, and predicts clinical-trial outcomes, compressing early discovery timelines. It works with major pharmaceutical companies via research collaborations and licenses its AI tools to drug developers.

Buyer Fit & Positioning

Procurement & Fit

Structured facts from the vendor to help your security, finance, and procurement reviews move faster.

Trust

Security & compliance

ISO 27001

SLA uptime target: Not specified

Security review turnaround: Not specified

DPA available: Not specified

Pricing

Commercial model

Pricing model: Custom quote

Free trial: No

Free plan: No

Contract minimum: Not specified

Procurement

Purchasing & legal

The vendor hasn’t added purchasing & legal details yet.

Fit

Best-fit company size

Company-size fit has not been specified yet.

Implementation & Procurement

Commercial Fit & Ecosystem

Proof, Outcomes & Momentum

Alternatives, Migration & Buyer Objections